Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease

Indian Journal of Gastroenterology

Volumn 28, Issue 2, 2009, Pages 53-58

  Abraham, Rachel ^a   Ramakrishna, Banumathi ^a   Balekuduru, Avinash ^a   Daniel, Hubert Darius J ^a   Abraham, Priya ^a   Eapen, C Eapen ^a   Kurian, George ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Fibrosis; Genotype; Hepatitis C; Histological activity; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; HYALIN; IRON; MALLORY HYALIN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; FATTY LIVER; FEMALE; GROUPS BY AGE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 3A; HEPATITS C VIRUS GENOTYPE 1; HUMAN; HUMAN TISSUE; INDIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MALLORY BODY; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; TREATMENT RESPONSE; VIRUS LOAD;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DNA, VIRAL; FATTY LIVER; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INDIA; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; PROTEINS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRANSAMINASES;

EID: 73249119544     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: 10.1007/s12664-009-0018-z     Document Type: Article

References (33)

1. Issar SK, Ramakrishna BS, Ramakrishna B, et al. Prevalence and presentation of hepatitis C related chronic liver disease in southern India. J Trop Med Hyg 1995;98:161-5.
2. Chakravarti A, Verma V. Prevalence of hepatitis C and B viral markers in patients with chronic liver disease: A study from northern India. Indian J Med Microbiol 2005;23:273-4.
3. Guillemette HLG, Vallet S, Graffi n CG, et al. Genetic diversity of the hepatitis C virus:impact and issues in the antiviral therapy. World J Gastroenterol 2007;13:2416-26.
4. Raghuraman S, Shaji RV, Sridharan G, et al. Distribution of different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol 2003;26:61-9.
5. Hissar SS, Goyal A, Kumar M, et al. Hepatitis C virus genotype 3 predominates in north and central India and is associated with signifi cant histopathologic liver disease. J Med Virol 2006;78:452-8.
6. Verma V, Chakravarti, Kar P. Genotypic characterization of hepatitis C virus and its signifi cance in patients with chronic liver disease from Northern India. Diagn Microbiol Infect Dis 2008;61:408-14.
7. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
8. Burt AD, Macsween RNM. Fat, alcohol and iron. In:Symmers W, Wight DGD, eds. Liver, biliary tract and exocrine pancreas. Systemic Pathology 3rd edn. London, UK: Churchill Livingstone; 1994:237-85.
9. Brandt LR, Leandro G, Spahr L, et al. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 2001;39:119-24.
10. Raghuraman S, Abraham P, Sridharan G, Ramakrishna BS. Hepatitis C virus genotype 6 infection in India. Indian J Gastroenterol 2005;24:72-3.
11. Mihm S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 1997; 25:735-9.
12. Adinolfi LE, Utili R, Andreana A, et al. Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients. Eur J Gastroenterol Hepatol 2000;12:299-304.
13. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fi brosis progression in patients with chronic hepatitis C. J Hepatol 2001;34:730-9.
14. Ryder SD. Progression of hepatic fi brosis in hepatitis C:a prospective repeat liver biopsy study. Gut 2004;53:451-5.
15. Nousbaum JB, Pol S, Nalpas B, et al. Hepatitis C virus type 1b(II) infection in France and Italy. Ann Intern Med 1995;122:161-8.
16. Roffi L, Redaelli A, Colloredo G, et al. Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C:infl uence of HCV genotype. Eur J Gastroenterol Hepatol 2001;13:501-6.
17. Karmochkine M, Carrat F, Santos OD, Cacoub P, Raguin G. A case control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat 2006;13:775-82.
18. Lee YS, Yoon SK, Chung ES, et al. The relationship of histological activity to serum ALT, HCV genotype and HCV RNA titres in chronic hepatitis C. J Korean Med Sci 2001;16:585-91.
19. Persico M, Persico E, Suozzo R, et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 2000;118:760-4.
20. Gholson CF, Morgan K, Catinis G, et al. Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. Am J Gastroenterol 1997;92:1788-92.
21. Saracco G, Sostegni R, Ghisetti V, et al. Hepatitis C virus genotypes in a non - cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre study. J Viral Hepat 2000;7:124-9.
22. McCormick SE, Goodman ZD, Maydonovitch CL, Sjogren MH. Evaluation of liver histology, ALT elevation and HCV RNA titer in patients with chronic hepatitis C. Am J Gastroenterol 1996;91:1516-22.
23. Kleiner DE. The liver biopsy in chronic hepatitis C:a view from the other side of the microscope. Semin Liver Dis 2005;25:52-64.
24. Rozario R, Ramakrishna B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J Hepatol 2003;38:223-9.
25. Silva GF, Nishimura NF, Coelho KIR, Soares EC. Grading and staging chronic hepatitis C and its relation to genotypes and epidemiological factors in Brazilian blood donors. Braz J Infect Dis 2005;9:142-9.
26. Ramalho F, Costa A, Pires A, et al. Correlation of genotypes and route of transmission with histological activity and disease stage in chronic hepatitis C. Dig Dis Sci 2000;45:182-7.
27. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatlogy 1996;24:289-93.
28. Negro F. Mechanisms and signifi cance of liver steatosis in chronic hepatitis C infection. World J Gastroenterol 2006; 12:6756-65.
29. Westin J, Norlinder H, Lagging M, Norkrans G, Wejstal R. Steatosis accelerates fi brosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol 2002; 37:837-42.
30. Amarapurkar DN, Patel ND, Rane P, Kamani P. Do different hepatitis C virus genotypes behave differently? Trop Gastroenterol 2007;28:99-104.
31. Metwally MA, Zein CO, Zein NN. Clinical signifi cance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 2004;286-91.
32. Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, Alberti A. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C. J Viral Hepat 2006;13:199-205.
33. Zhao S, Liu E, Yu H, et al. Comparison of peginterferon and interferon in treating Chinese patients with chronic hepatitis C. Hepatogastroenterology 2008;55:1047-54.